Ginkgo Bioworks Holdings, Inc. today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional details on the third ...
Ginkgo reaffirmed its full-year 2025 revenue guidance of $167 million to $187 million, with Cell Engineering revenue expected to be $117 million to $137 million and Biosecurity revenue expected to be ...